title: Establishing cost-effectiveness of atypical neuroleptics.
authors.forename: G
authors.initials: G
authors.lastname: Robert
authors.forename: P
authors.initials: P
authors.lastname: Kennedy
mesh_terms: D014150:Antipsychotic Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D013673:Technology Assessment, Biomedical
chemical_list: D014150:Antipsychotic Agents